ALICIA POST: Open Payments
NPI 1376218321 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$580 in 27 payments from 11 companies in 2025. Trend: 2023 $238 · 2024 $564 · 2025 $580
Food & beverage: $580
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $108 |
| Amgen Inc. | 5 | $89 |
| Novo Nordisk Inc | 3 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $64 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| ABBVIE INC. | 2 | $51 |
| Lilly USA, LLC | 2 | $41 |
| Dexcom, Inc. | 1 | $41 |
| Astellas Pharma US Inc | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: NURTEC ODT, XIFAXAN, EVENITY, MOUNJARO, Dexcom G6 Transmitter, SHINGRIX, OTEZLA, Veozah.
Industry payments across MD — which companies pay providers there.
